Sublingual or injection immunotherapy: The final answer?

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 59, Issue 1, 2004, Pages 37-38

  Passalacqua, G ^a,b   Canonica, G W ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b DIMI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOLOGIC AGENT;

ASTHMA; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; FOLLOW UP; HUMAN; IMMUNOTHERAPY; INJECTION; PRIORITY JOURNAL; QUALITY OF LIFE; RHINITIS; SIDE EFFECT;

ADMINISTRATION, SUBLINGUAL; ANTI-ALLERGIC AGENTS; ASTHMA; FEMALE; HUMANS; IMMUNOTHERAPY; INJECTIONS, SUBCUTANEOUS; MALE; RANDOMIZED CONTROLLED TRIALS; RHINITIS, ALLERGIC, PERENNIAL; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0842287299     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1398-9995.2003.00397.x     Document Type: Editorial

References (19)

1. CANONICA GW, PASSALACQUA G. Non-injection routes for immunotherapy. J Allergy Clin Immunol 2003;111:437-448.
2. PASSALACQUA G, ALBANO M, FREGONESE L, RICCIO A, PRONZATO C, MELA GS et al. Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite induced rhinoconjunctivitis. Lancet 1998;351:629-632.
3. PASSALACQUA G, ALBANO M, RICCIO AM, PARMIANI S, PUCCINELLI P, CANONICA GW. Clinical and immunological effects of a rush sublingual immunotherapy to parietaria species: a double blind placebo controlled trial. J Allergy Clin Immunol 1999;104:964-968.
4. IPPOLITI F, DE SANCTIS W, VOLTERRANI A, LENTI L, CANITANO N, LUCARELLI S et al. Immunomodulation during sublingual therapy in allergic children. Pediatr Allergy Immunol 2003;14:216-221.
5. DI RIENZO V, PAGANI A, PARMIANI S, PASSALACQUA G, CANONICA GW. Post-marketing surveillance study on the safety of sublingual immunotherapy in children. Allergy 1999;54:1110-1113.
6. LOMBARDI C, GARGIONI S, MELCHIORRE A, TIRI A, FALAGIANI P, CANONICA GW et al. Safety of sublingual immunotherapy in adults: a post marketing surveillance study. Allergy 2001;56: 889-892.
7. DI RIENZO V, MARCUCCI F, PUCCINELLI P, PARMIANI S, FRATI F, SENSI L et al. Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a ten year prospective study. Clin Exp Allergy 2003;33:206-210.
8. WILSON DR, TORRES LIMA I, DURHAM SR. Sublingual immunotherapy for allergic rhinitis (Cochrane review). Cochrane Database Syst Rev. 2003;2:CD002893.
9. BOUSQUET J, VAN CAUWENBERGE P (eds). Allergic rhinits and its impact on asthma. J Allergy Clin Immunol 2001; 108(5 Suppl.):S240-S245.
10. BROWN JL, FREW AJ. The efficacy of oromucosal immunoterapy in respiratory allergy. Clin Exp Allergy 2001;31:8-10
11. NELSON HS. Advances in upper airway disease and allergen immunotherapy. J Allergy Clin Immunol 2003;111: S793-S798.
12. CAARELLI C, SENSI LG, MARCUCCI F, CAVAGNI C. Preseasonal local allergoid immunotherapy to grass pollen in children: a double-blind, placebo-controlled, randomized trial. Allergy 2000; 55:1142-1147.
13. LA ROSA M, RANNO C, ANDRE' C et al. Double blind placebo controlled evaluation of sublingual swallow immuno-therapy with standardized parietaria judaica extract in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 1999;104:425-432.
14. QUIRINO T, IEMOLI E, SICILIANI E, PARMIANI S. Sublingual vs injective immunotherapy in grass pollen allergic patients: a double blind double dummy study. Clin Exp Allergy 1996;26: 1253-1261.
15. ONGARI S, DOMENEGHETTI P, PARMIANI S. Comparison among drugs, injective IT and sublingual IT in grass allergic patients. Allergy 1995;50:358.
16. BERNARDIS P, AGNOLETTO M, PUCCINELLI P, PARMIANI S, POZZAN M. INJECTIVE VS sublingual immunotherapy in Alternaria tenuis allergic patients. J Invest Allergol Clin Immunol 1996;6: 55-62.
17. PIAZZA I, BIZZARRO N. Humoral response to subcutaneous, oral and nasal immunotherapy for allergic rhinitis due to Dermatophagoides pteronyssinus. Ann Allergy 1993;71:461-469.
18. MUNGAN D, MISIRLIGIL Z, GURBUZ L. Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite sensitive patients with rhinitis and asthma: a placebo controlled study. Ann Allergy Asthma Immunol 1999;82:485-490.
19. KHINCHI MS, POULSEN LK, CARAT F, ANDRÈ C, HANSEN AB, MALLING H-J. Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study. Allergy 2004;59:45-53.